PMID- 38374779 OWN - NLM STAT- MEDLINE DCOM- 20240318 LR - 20240318 IS - 1897-4279 (Electronic) IS - 0022-9032 (Linking) VI - 82 IP - 2 DP - 2024 TI - Is the 2016 ESC diagnostic algorithm useful for assessing the prevalence of chronic heart failure in population-based studies? PG - 175-182 LID - 10.33963/v.phj.98958 [doi] AB - BACKGROUND: Chronic heart failure (CHF) is a major healthcare problem. However, there are no epidemiological studies assessing the prevalence of CHF in the general population with diagnosis based on algorithms recommended for clinical practice. AIM: The aim of the HF-Pomorskie survey was to assess the prevalence of three basic components of the 2016 ESC diagnostic algorithm for CHF (symptoms, N-terminal pro B-type natriuretic peptide [NT-proBNP], and abnormalities on echocardiography) and to determine whether this algorithm may be applicable to studies in general population samples. METHODS: The study was performed in a representative sample of 313 adults (170 women and 143 men) aged between 20 and 90 years (mean 55.2 years [15.3]) in Northern Poland. A questionnaire to determine New York Heart Association [NYHA] class, laboratory tests including NT-proBNP, as well as transthoracic echocardiography and spirometry examinations were performed in all subjects. RESULTS: Dyspnea (NYHA class II-IV) was reported by 13.7% of recruited participants. Dyspnea and elevated levels of NT-proBNP (>125 pg/ml) were found in 7.7% of all examined subjects, while dyspnea, elevated NT-proBNP levels accompanied by systolic or diastolic abnormalities on echocardiography occurred in 4.8%. In the group without dyspnea (86.3% of all examined subjects), every sixth subject had an elevated level of NT-proBNP. On the other hand, 5.8% of studied subjects reported a previous diagnosis of CHF, which was confirmed using the current ESC algorithm in 78% of them. CONCLUSIONS: The prevalence of CHF assessed by the 2016 ESC diagnostic algorithm in the representative sample of adults was equal to 4.8%. The clinical algorithm for the diagnosis of CHF is fully applicable to the representative surveys in the general population. However, due to logistic and economic factors, echocardiography examination and NT-proBNP determination can be limited to patients reporting dyspnea or previous diagnosis of CHF. FAU - Puch-Walczak, Aleksandra AU - Puch-Walczak A AD - Department of Preventive Medicine and Education, Medical University of Gdansk, Gdansk, Poland. apw@gumed.edu.pl. FAU - Kunicka, Katarzyna AU - Kunicka K AD - Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland. FAU - Jagiello, Kacper AU - Jagiello K AD - Department of Preventive Medicine and Education, Medical University of Gdansk, Gdansk, Poland. FAU - Puzio, Ewa AU - Puzio E AD - Department of Cardiac Diagnostics, Medical University of Gdansk, Gdansk, Poland. FAU - Jankowska, Hanna AU - Jankowska H AD - Department of Cardiac Diagnostics, Medical University of Gdansk, Gdansk, Poland. FAU - Hoffman, Piotr AU - Hoffman P AD - Department of Congenital Heart Diseases, National Institute of Cardiology, Warszawa, Poland. FAU - Dudziak, Maria AU - Dudziak M AD - Department of Cardiac Diagnostics, Medical University of Gdansk, Gdansk, Poland. FAU - Kuziemski, Krzysztof AU - Kuziemski K AD - Department of Pulmonology, Medical University of Gdansk, Gdansk, Poland. FAU - Drygas, Wojciech AU - Drygas W AD - Department of Social and Preventive Medicine, Medical University of Lodz, Lodz, Poland. AD - Department of Epidemiology, Cardiovascular Disease Prevention and Health Promotion, Institute of Cardiology, Warszawa, Poland. FAU - Zdrojewski, Tomasz AU - Zdrojewski T AD - Department of Preventive Medicine and Education, Medical University of Gdansk, Gdansk, Poland. LA - eng PT - Journal Article DEP - 20240220 PL - Poland TA - Kardiol Pol JT - Kardiologia polska JID - 0376352 SB - IM MH - Male MH - Adult MH - Humans MH - Female MH - Young Adult MH - Middle Aged MH - Aged MH - Aged, 80 and over MH - Prevalence MH - *Heart Failure/diagnosis/epidemiology MH - Chronic Disease MH - Algorithms MH - Dyspnea/diagnosis/epidemiology OTO - NOTNLM OT - ESC guidelines OT - NT-proBNP OT - NYHA scale OT - epidemiology OT - heart failure EDAT- 2024/02/20 11:50 MHDA- 2024/03/18 06:43 CRDT- 2024/02/20 03:23 PHST- 2024/01/16 00:00 [received] PHST- 2024/01/16 00:00 [accepted] PHST- 2024/03/18 06:43 [medline] PHST- 2024/02/20 11:50 [pubmed] PHST- 2024/02/20 03:23 [entrez] AID - VM/OJS/J/98958 [pii] AID - 10.33963/v.phj.98958 [doi] PST - ppublish SO - Kardiol Pol. 2024;82(2):175-182. doi: 10.33963/v.phj.98958. Epub 2024 Feb 20.